Arkolith/Insider Trading/MRTX/Form 4

Hasnain Faheem

DirectorMirati Therapeutics, Inc. (MRTX) · full profile →Form 4 · filed Jan 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 23, 2024Disposed to issuer(D)6K——10K
Jan 23, 2024Disposed to issuer(D)10K——0
Jan 23, 2024Disposed to issuer(D)9K——16K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 23, 2024Disposed to issuer(D)35K——0
Jan 23, 2024Disposed to issuer(D)10K——0
Jan 23, 2024Disposed to issuer(D)11K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-24-003533) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML